Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia (Q38014115)

27 August 2017

title

Treatment of asymptomatic catecholaminergic polymorphic ventricular tachycardia (English)

1 reference

catecholaminergic polymorphic ventricular tachycardia

27 August 2017

main subject

0 references

author name string

Manoj N Obeyesekere

1

1 reference

27 August 2017

Raymond W Sy

2

1 reference

27 August 2017

Peter Leong-Sit

3

1 reference

27 August 2017

Lorne J Gula

4

1 reference

27 August 2017

Raymond Yee

5

1 reference

27 August 2017

Allan C Skanes

6

1 reference

27 August 2017

George J Klein

7

1 reference

27 August 2017

Andrew D Krahn

8

1 reference

27 August 2017

publication date

1 May 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

439-450

1 reference

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia

27 August 2017

cites work

1 reference

Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2 ) regulation

21 January 2018

1 reference

Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing

21 January 2018

1 reference

Bidirectional tachycardia in a child. A study using His bundle electrography

21 January 2018

1 reference

Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts

21 January 2018

1 reference

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

21 January 2018

1 reference

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

21 January 2018

1 reference

Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia

21 January 2018

1 reference

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

21 January 2018

1 reference

Inherited dysfunction of sarcoplasmic reticulum Ca2 handling and arrhythmogenesis

21 January 2018

1 reference

The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms?

21 January 2018

1 reference

A cardiac arrhythmia syndrome caused by loss of ankyrin-B function

21 January 2018

1 reference

Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features

21 January 2018

1 reference

Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives

21 January 2018

1 reference

Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation

21 January 2018

1 reference

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death

21 January 2018

1 reference

Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

21 January 2018

1 reference

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers.

21 January 2018

1 reference

Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing.

21 January 2018

1 reference

The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading [...]

21 January 2018

1 reference

Ryanodine receptors and ventricular arrhythmias: emerging trends in mutations, mechanisms and therapies

21 January 2018

1 reference

High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening

21 January 2018

1 reference

Active cascade screening in primary inherited arrhythmia syndromes: does it lead to prophylactic treatment?

21 January 2018

1 reference

21 January 2018

1 reference

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

21 January 2018

1 reference

Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments

21 January 2018

1 reference

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations

21 January 2018

1 reference

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

21 January 2018

1 reference

Flecainide inhibits arrhythmogenic Ca2 waves by open state block of ryanodine receptor Ca2 release channels and reduction of Ca2 spark mass.

21 January 2018

1 reference

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias: the surgical supraclavicular approach to cervicothoracic sympathectomy

21 January 2018

1 reference

Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery

21 January 2018

1 reference

The rationale and the role of left stellectomy for the prevention of malignant arrhythmias

21 January 2018

1 reference

An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial

21 January 2018

1 reference

Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia

21 January 2018

1 reference

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

21 January 2018

1 reference

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

21 January 2018

1 reference

Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FCA.12.12

1 reference

27 August 2017

1 reference